Shimadzu
Shimadzu Corporation is a Japanese public KK company, manufacturing precision instruments, measuring instruments and medical equipment, based in Kyoto, Japan. It was established in 1875. The American arm of the company, Shimadzu Scientific Instruments, was founded in 1975.
History
Founding and early years
The company was established by Genzo Shimadzu Sr. in 1875. During the 1890s and 1900s, Shimadzu experienced rapid growth that occurred at the same time as higher education grew in Japan.X-ray devices, the spectrum camera, the electron microscope, and the gas chromatograph were developed and commercialized in advance of other Japanese companies. Shimadzu became a corporation in 1917. The American arm of the company, Shimadzu Scientific Instruments, was founded in 1975.
Genzo Shimadzu Sr's son Genzo Shimadzu Jr was the second president of the company and also founded battery manufacturer GS in 1917.
Developments
The company also developed, in 2001, an ultra-high speed video camera, HyperVision HPV-1, which is capable of recording at 1,000,000 FPS, while in 2016 it released the HyperVision HPV-X2, a camera that achieves ultra-high-speed continuous recording at 10 million frames per second at Full Pixel Resolution. Other products developed by Shimadzu include head-mounted displays.The company had revenue of ¥264.048 billion yen in FY 2012, with 10,395 employees as of March 31, 2013.
Acquisition history
In 2024, Shimadzu's scientific Instruments "SSI" acquired ZefSci to strengthen their core position in the Multi Vendor Space.In 2019, Shimadzu's Medical subsidiary in USA acquired CORE Medical Imaging, Inc. to strengthen healthcare business in North America.
In 2018, Shimadzu acquired Infraserv Vakuumservice GmbH of Germany in order to strengthen their turbomolecular pump sales and service capabilities in Europe.
In 2017, Shimadzu acquired AlsaChim, a specialist for high-quality analytical isotope labeled standards.
In 1989, Shimadzu Corporation acquired Kratos Group Plc. in U.K. to expand in surface analysis and MALDI-TOF segments.